Repurposing therapies in junctional epidermolysis bullosa: ivermectin may influence RNA splicing and improve functional protein expression
Published: 10 October 2025| Version 1 | DOI: 10.17632/gxvj525fnx.1
Contributors:
, , , Description
Clinical images of subject patient's lower limbs demonstrating improved wound re-epithelialisation with continued oral ivermectin therapy from February 2021 (Fig. 1), after four months of therapy in June 2021 (Fig. 2), and after one year of therapy in April 2022 (Fig. 3).
Files
Institutions
- University of New South Wales
Categories
Dermatology, Antiparasitic Drug, Epidermolysis bullosa, Skin Blistering, Ivermectin, Complex Wound